Beyond traditional NMAs: flexible time-to-event NMAs
On Demand Webinar
In the third webinar of Cytel's Comparative Effectiveness series. Led by Bart Heeg, Gabriel Tremblay, and Emma Mackay, this webinar will delve into Flexible time-to-event NMAs and their consequences. The experts will highlight the significance of Bayesian hierarchical TTE NMA in overcoming immature pivotal trial data.
During the session, Emma will present a case study that focuses on Bayesian hierarchical TTE NMAs for tumor agnostic trials. Gabriel will also discuss the application of theses from a HTA modelling acceptance perspective.
Join us for this informative session and gain valuable insights into the importance of Flexible time-to-event NMAs and the Bayesian hierarchical TTE NMA.
- Bart Heeg, Vice President HEOR Global, Cytel
- Gabriel Tremblay, Vice President, Advanced Analytics
- Emma Mackay, Research Principal, Statistics